We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$140B
AUM Growth
+$5.37B
Cap. Flow
+$13.5B
Cap. Flow %
9.64%
Top 10 Hldgs %
30.28%
Holding
6,714
New
321
Increased
2,151
Reduced
2,607
Closed
759

Sector Composition

Rank Sector Weight
1 Technology 8.94%
2 Healthcare 5.53%
3 Financials 5.03%
4 Consumer Discretionary 4.6%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPUH.U
6301
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
-150
Closed -$1K
CPUH
6302
DELISTED
Compute Health Acquisition Corp.
CPUH
-247,767
Closed -$2.43M
HGEN
6303
DELISTED
HUMANIGEN, INC.
HGEN
$0 ﹤0.01%
10
-4,376
-100% -$2.35K
NMTR
6304
DELISTED
9 Meters Biopharma
NMTR
-3,487
Closed -$18K
SEV
6305
DELISTED
Sono Group N.V. Common Shares
SEV
-4,000
Closed -$12K
IMBI
6306
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
-2,950
Closed -$4K
NYMX
6307
DELISTED
Nymox Pharmaceutical Corp
NYMX
-1,474
Closed -$1K
SQZ
6308
DELISTED
SQZ Biotechnologies Company
SQZ
$0 ﹤0.01%
16
-548
-97% -$1.64K
HEXO
6309
DELISTED
HEXO Corp. Common Shares
HEXO
-2,179
Closed -$6.2K
STCN
6310
DELISTED
Steel Connect, Inc. Common Stock
STCN
-311
Closed -$4K
ONCR
6311
DELISTED
Oncorus, Inc.
ONCR
$0 ﹤0.01%
491
-1,635
-77% -$2.1K
ILLM
6312
DELISTED
illumin Holdings Inc. Common Shares
ILLM
-6,095
Closed -$14K
HVBC
6313
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
$0 ﹤0.01%
+1
New +$21
FNCH
6314
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-2
Closed
RONI.U
6315
DELISTED
Rice Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RONI.U
-1,000
Closed -$10K
RONI.WS
6316
CALL
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
-6,251
Closed -$2K
WEJO
6317
DELISTED
Wejo Group Limited Common Shares
WEJO
$0 ﹤0.01%
349
-2,216
-86% -$2.89K
APTO
6318
DELISTED
Aptose Biosciences, Inc.
APTO
0
ACOR
6319
DELISTED
Acorda Therapeutics
ACOR
$0 ﹤0.01%
+72
New +$602
BLCM
6320
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
+125
New +$159
MNTV
6321
CALL
DELISTED
Momentive Global Inc. Common Stock
MNTV
-30,500
Closed -$268K
MNTV
6322
PUT
DELISTED
Momentive Global Inc. Common Stock
MNTV
-1,433,900
Closed -$12.6M
PNTM
6323
DELISTED
Pontem Corporation
PNTM
-232,929
Closed -$2.29M
LABP
6324
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$0 ﹤0.01%
50
-24
-32% -$208
SGTX
6325
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-35
Closed

Similar funds

Citigroup's Q3 2022 Portfolio in Review

As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.

  • Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
  • Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
  • Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
  • Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
  • Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
  • Citigroup opened 321 new positions and closed 759 in Q3 2022.
  • Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.